As of July 28, 10.3 million adolescents received at least one vaccine shot, according to data from the Centers for Disease Control and Prevention (CDC). That’s 41% of adolescents nationwide.
The Food and Drug Administration approved the Pfizer-BioNTech vaccine for use among people aged 12 to 15 in May. (Two other vaccines made by Moderna and Johnson & Johnson are not available to people under 18.) It had previously been available to people 16 and older. Since the vaccine eligibility age dropped, adolescents accounted for 7.7 million of 33.9 newly vaccinated people.
